Investors Relations
The work of the Board
The Board is actively supervising the activities of the Company through frequent board meetings and meetings with the management. The Board has adopted an annual meeting plan for its work. As per April 14th 2008, the Board has resolved board instructions and instructions for the CEO detailing the work and responsibilities of the Board and the CEO, respectively.
The Board continuously evaluates the need for sub-committees. Currently, the Board has not established a Remuneration Committee or registered an Audit committee as sub-committees of the Board.
Currently, the Board has not conducted annual formal self-evaluations.
Contact Us
For more information, please visit our profile on the Oslo Stock Exchange website or contact:
Erik Tjørstad
CFO
erik@nattopharma.com
Tel: (+47) 916 36 395